Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology

被引:48
|
作者
Hatamoto, Masashi [1 ]
Ohashi, Akiyoshi [1 ]
Imachi, Hiroyuki [2 ]
机构
[1] Hiroshima Univ, Dept Social & Environm Engn, Hiroshima 7398527, Japan
[2] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Extremobiosphere Res Program, Subsurface Geobiol Adv Res SUGAR Team, Kanagawa 2370061, Japan
关键词
Bacterial growth; Environmental microbiology; Antisense; rRNA; IN-SITU ACCESSIBILITY; ESCHERICHIA-COLI; GENE-EXPRESSION; RIBOSOMAL-RNA; INHIBITION; OLIGOMER; PROTEIN; TRANSLATION; SEQUENCE;
D O I
10.1007/s00253-009-2387-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Peptide nucleic acids (PNAs) are nucleic acid analogs having attractive properties such as quiet stability against nucleases and proteases, and they form strong complexes with complementary strands of DNA or RNA. Because of this attractive nature, PNA is often used in antisense technology to inhibit gene expression and microbial cell growth with high specificity. Many bacterial antisense or antiribosomal studies using PNA oligomers have been reported so far, and parameters to design effective antisense PNAs and to improve PNA cell entry for efficient inhibition of bacterial growth have been presented. However, there are still several obstacles such as low cellular uptake of PNA while applying antisense PNAs to a complex microbial community. On overcoming these problems, the PNA antisense technique might become a very attractive tool not only for controlling the microbial growth but also for further elucidating microbial ecology in complex microbial consortia. Here, we summarize and present recent studies on the development of antimicrobial PNAs targeting mRNAs and rRNAs. In addition, the application potentiality of antisense techniques in nonclinical biotechnology fields is discussed.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 50 条
  • [21] Pretargeting with amplification using polymeric peptide nucleic acids (PNAS).
    Wang, Y
    Chang, F
    Zhang, YM
    Liu, N
    Liu, G
    Gupta, S
    Rusckowski, M
    Hnatowich, DJ
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 70P - 70P
  • [22] Peptide nucleic acids (PNAs): currently potential bactericidal agents
    Narenji, Hanar
    Gholizadeh, Pourya
    Aghazadeh, Mohammad
    Rezaee, Mohammad Ahangarzadeh
    Asgharzadeh, Mohammad
    Kafil, Hossein Samadi
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 : 580 - 588
  • [23] Redesigned nucleic acids and their application to biotechnology
    Benner, SA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U264 - U264
  • [24] A theoretical analysis of specificity of nucleic acid interactions with oligonucleotides and peptide nucleic acids (PNAs)
    Lomakin, A
    Frank-Kamenetskii, MD
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 276 (01) : 57 - 70
  • [25] Peptide Nucleic Acids (PNAs) for alterations of biological activity of micro RNAs
    Gambari, Roberto
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S62 - S62
  • [26] The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics
    Pellestor, F
    Paulasova, P
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (09) : 694 - 700
  • [27] Emerging technologies in the design of peptide nucleic acids (PNAs) based biosensors
    Moccia, Maria
    Antonacci, Amina
    Saviano, Michele
    Caratelli, Veronica
    Arduini, Fabiana
    Scognamiglio, Viviana
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2020, 132
  • [28] The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics
    Franck Pellestor
    Petra Paulasova
    European Journal of Human Genetics, 2004, 12 : 694 - 700
  • [29] Chiral peptide nucleic acids (PNAs): Helix handedness and DNA recognition
    Sforza, S
    Haaima, G
    Marchelli, R
    Nielsen, PE
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 1999, 1999 (01) : 197 - 204
  • [30] Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis
    Pellestor, Franck
    Paulasova, Petra
    Hamamah, Samir
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (24) : 2439 - 2444